Reaktionsgleichung
Cl[C:2]1[CH:11]=[CH:10][C:9]2[C:8]([NH2:12])=[C:7]([Cl:13])[CH:6]=[CH:5][C:4]=2[N:3]=1.[NH:14]1[CH2:19][CH2:18][CH:17]([C:20]([O:22][CH2:23][CH3:24])=[O:21])[CH2:16][CH2:15]1>>[NH2:12][C:8]1[C:7]([Cl:13])=[CH:6][CH:5]=[C:4]2[C:9]=1[CH:10]=[CH:11][C:2]([N:14]1[CH2:19][CH2:18][CH:17]([C:20]([O:22][CH2:23][CH3:24])=[O:21])[CH2:16][CH2:15]1)=[N:3]2Komponenten
3
Versuchsvorschrift
Prepared according to the method of example 30, using 2,6-dichloroquinolin-5-amine (Example 1(d)) (800 mg) and 4-piperidinecarboxylic acid, ethyl ester (1.8 g). Purification (SiO2, miethanol:dichloromethane 1:99 as eluant) gave the sub-title compound as a solid (900 mg).
Aufarbeitung
- customPrepared
- customPurification (SiO2, miethanol:dichloromethane 1:99 as eluant)
Quellen und Nachweise
- ORD-Eintrag
- ord-5e1c6f6da2c841d0bdbd637d4977daf3
- Quelldatensatz
- uspto-grants-2008_08
- Patentnummer
- US07408065B2
Verknüpfte Notizen
Wird geladen…